Emperra said today that it closed a Series B round worth $3.1 million for its Esysta “smart” diabetes management system. Potsdam, Germany-based Emperra said the VC arm of the Bosch Group, Robert Bosch Venture Capital, joined existing backers Peppermint VenturePartners and Investitionsbank des Landes Brandenburg. CEO Christian Krey and CTO Dr. Janko Schildt also got in on the round, Emperra said. Esysta, which […]